SCHEMBL7929992

SCHEMBL7929992

COOB(O)c1ccc2cc(OC(C)OC)c(C34CC5CC(CC(C5)C3)C4)cc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARA P10276 3/20 0.38
RARB P10826 3/20 0.38
RARG P13631 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NR1I2 O75469 1/20 0.38
LMNA P02545 1/20 0.38
PGR P06401 1/20 0.38
HSPD1 P10809 1/20 0.38
GOT1 P17174 1/20 0.38
GLRA1 P23415 1/20 0.38
BLM P54132 1/20 0.38
HSPE1 P61604 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HDAC11 Q96DB2 2/20 0.33
THRB P10828 1/20 0.33
RECQL P46063 1/20 0.33
NR2E1 Q9Y466 1/20 0.33
HDAC2 Q92769 1/20 0.31
CASP1 P29466 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7691266 0.79 MEN1 (0.40) RARARARBRARGMEN1KMT2A
SCHEMBL7920782 0.78 RARA (0.37) RARARARBRARGMEN1KMT2A
SCHEMBL7920784 0.76 RARA (0.37) RARARARBRARGMEN1KMT2A
SCHEMBL7927692 0.75 RARA (0.40) RARARARBRARGMEN1KMT2A
SCHEMBL8650407 0.69 RARB (0.48) RARARARBRARGMEN1KMT2A
SCHEMBL8688116 0.69 RARA (0.38) RARARARBRARGMEN1KMT2A
SCHEMBL8688120 0.69 MEN1 (0.35) RARARARBRARGMEN1KMT2A
SCHEMBL7920787 0.68 IKBKB (0.49) RARARARBRARGMEN1KMT2A
SCHEMBL7920649 0.67 CNR2 (0.39) RARARARBRARGMEN1KMT2A
SCHEMBL7689452 0.67 RARA (0.36) RARARARBRARGMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6225328-B1 FOR THERAPY OF DISORDERS OR AILMENTS RELATED TO AN OVERREGULATION OF RETINOIC ACID RECEPTORS AND/OR TO HYPERVIAMINOSIS A CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2001-05-01 US disclosed
US-5952382-A INHIBITING THE BIOLOGICAL EFFECTS OF AN OVERREGULATION OF RETINOID ACID RECEPTORS AND/OR OF A HYPERVITAMINOSIS A; TREATING SKIN DISORDER, EYE VISION DEFECTS, SKIN AGING CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1999-09-14 US disclosed